Emcure Pharmaceuticals Limited
Axis Mutual Fund bought 1,37,590 shares of Emcure Pharmaceuticals for ₹25.00 Cr at ₹1817.00 apiece in a block deal.
A global pharmaceutical manufacturer established in 1981, Emcure Pharmaceuticals produces and markets a comprehensive range of drug formulations across multiple therapeutic areas for domestic and international markets. The company operates manufacturing facilities that serve patients globally, focusing on both generic and specialty pharmaceutical products. Emcure's diversified operations and geographic presence establish it as a significant player in the pharmaceutical industry.
Subsidiary of Axis Bank, India's third-largest private sector bank. Manages over Rs 3.5 lakh crore in AUM. Built its brand on a quality growth equity philosophy with concentrated high-conviction portfolios. Flagship Axis Flexi Cap and Axis Bluechip funds are widely held among retail investors and drove significant AUM growth through the 2017-2021 bull cycle.